SCHEMBL28826192

SCHEMBL28826192

CN1CC[C@@H](NC(=O)OC(C)(C)C)[C@@H](F)C1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 10/20 0.47
SSTR1 P30872 6/20 0.47
CTSK P43235 2/20 0.45
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
BTK Q06187 1/20 0.38
CYP2C9 P11712 1/20 0.38
HSD11B1 P28845 1/20 0.38
GAA P10253 1/20 0.38
DRD2 P14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18909588 0.88 CTSK (0.45) SSTR4SSTR1CTSKCA1CA2
SCHEMBL31368050 0.86 CTSK (0.41) SSTR4SSTR1CTSKCA1CA2
SCHEMBL24928078 0.86 CTSK (0.41) SSTR4SSTR1CTSKCA1CA2
SCHEMBL24928082 0.86 CTSK (0.41) SSTR4SSTR1CTSKCA1CA2
SCHEMBL19465291 0.84 CTSK (0.46) SSTR4SSTR1CTSKCA1CA2
SCHEMBL24854857 0.84 CTSK (0.46) SSTR4SSTR1CTSKCA1CA2
SCHEMBL20070141 0.84 CTSK (0.46) SSTR4SSTR1CTSKCA1CA2
SCHEMBL16058570 0.83 CTSK (0.43) CTSKCA1CA2NFKB1NFKB2
SCHEMBL16058571 0.83 CTSK (0.43) CTSKCA1CA2NFKB1NFKB2
SCHEMBL31634070 0.83 USP30 (0.47) CTSKCA1CA2CYP2C9HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235389-A1 P53 MODULATORS NESTED THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed
WO-2024215802-A1 BENZOFURANYL AND BENZOTHIENYL COMPOUNDS AS P53 MODULATORS NESTED THERAPEUTICS, INC. (US) 2024-10-17 WO disclosed
CN-115003299-A Methods and compounds for restoring function of mutant p53 皮姆维制药公司 2022-09-02 CN disclosed